Pre-order Enquiry
Request Free Sample
Global Benzphetamine Market Insights, Forecast to 2028
SKU ID : QYR-20154914 | Publishing Date : 08-Feb-2022 | No. of pages : 95
Request Sample
Request Customization
Check Discounts
Benzphetamine is a substituted amphetamine used short-term along with a doctor-approved, reduced-calorie diet, exercise, and behavioral program for weight loss. It is prescribed for obesity in individuals who have been unable to lose weight through exercise and dieting alone. It is a prodrug to dextroamphetamine and dextromethamphetamine
Market Analysis and Insights: Global Benzphetamine Market
Due to the COVID-19 pandemic, the global Benzphetamine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 25mg accounting for % of the Benzphetamine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Benzphetamine market size is valued at US$ million in 2021, while the US and Europe Benzphetamine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Benzphetamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Benzphetamine include Corepharma, Impax laboratories, Perrigo, Mallinckrodt, Pfizer, Boca Pharmacal, Nivagen Pharmaceuticals, Tedor Pharma and Pd Rx Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Benzphetamine Scope and Segment
Benzphetamine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Benzphetamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
25mg
50mg
Segment by Application
Hospital
Drug Store
By Company
Corepharma
Impax laboratories
Perrigo
Mallinckrodt
Pfizer
Boca Pharmacal
Nivagen Pharmaceuticals
Tedor Pharma
Pd Rx Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Market Analysis and Insights: Global Benzphetamine Market
Due to the COVID-19 pandemic, the global Benzphetamine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 25mg accounting for % of the Benzphetamine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Benzphetamine market size is valued at US$ million in 2021, while the US and Europe Benzphetamine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Benzphetamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Benzphetamine include Corepharma, Impax laboratories, Perrigo, Mallinckrodt, Pfizer, Boca Pharmacal, Nivagen Pharmaceuticals, Tedor Pharma and Pd Rx Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Benzphetamine Scope and Segment
Benzphetamine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Benzphetamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
25mg
50mg
Segment by Application
Hospital
Drug Store
By Company
Corepharma
Impax laboratories
Perrigo
Mallinckrodt
Pfizer
Boca Pharmacal
Nivagen Pharmaceuticals
Tedor Pharma
Pd Rx Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
